 | • レポートコード：GIR201109419 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、滑膜肉腫治療の世界市場を調査対象にし、滑膜肉腫治療の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（ACXT-3102、AL-3818、アキシチニブ、CMB-305、CUE-102、その他）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Adaptimmune Therapeutics Plc、Merck & Co Inc、Immune Design Corp、Advenchen Laboratories LLC、Karyopharm Therapeutics Inc、EpiZyme Inc、Novartis AG、Johnson & Johnson、Immunocore Ltd、Millennium Pharmaceuticals Inc、Pfizer Inc、Takara Bio Inc ・メーカー別販売量、売上、市場シェア ・滑膜肉腫治療の地域別市場分析 ・滑膜肉腫治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・滑膜肉腫治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・滑膜肉腫治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・滑膜肉腫治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・滑膜肉腫治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・滑膜肉腫治療の種類別市場規模2015-2020：ACXT-3102、AL-3818、アキシチニブ、CMB-305、CUE-102、その他 ・滑膜肉腫治療の用途別市場規模2015-2020：病院、クリニック、その他 ・滑膜肉腫治療の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Synovial Sarcoma Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Synovial Sarcoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Synovial Sarcoma Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Synovial Sarcoma Treatment market has been segmented into
ACXT-3102
AL-3818
Axitinib
CMB-305
CUE-102
Others
By Application, Synovial Sarcoma Treatment has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Synovial Sarcoma Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Synovial Sarcoma Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Synovial Sarcoma Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Synovial Sarcoma Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Synovial Sarcoma Treatment Market Share Analysis
Synovial Sarcoma Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Synovial Sarcoma Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Synovial Sarcoma Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Synovial Sarcoma Treatment are:
Adaptimmune Therapeutics Plc
Merck & Co Inc
Immune Design Corp
Advenchen Laboratories LLC
Karyopharm Therapeutics Inc
EpiZyme Inc
Novartis AG
Johnson & Johnson
Immunocore Ltd
Millennium Pharmaceuticals Inc
Pfizer Inc
Takara Bio Inc
Among other players domestic and global, Synovial Sarcoma Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Synovial Sarcoma Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Synovial Sarcoma Treatment, with price, sales, revenue and global market share of Synovial Sarcoma Treatment in 2018 and 2019.
Chapter 3, the Synovial Sarcoma Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Synovial Sarcoma Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Synovial Sarcoma Treatment market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Synovial Sarcoma Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Synovial Sarcoma Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Synovial Sarcoma Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 ACXT-3102
1.2.3 AL-3818
1.2.4 Axitinib
1.2.5 CMB-305
1.2.6 CUE-102
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Synovial Sarcoma Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Overview of Global Synovial Sarcoma Treatment Market
1.4.1 Global Synovial Sarcoma Treatment Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Adaptimmune Therapeutics Plc
2.1.1 Adaptimmune Therapeutics Plc Details
2.1.2 Adaptimmune Therapeutics Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Adaptimmune Therapeutics Plc SWOT Analysis
2.1.4 Adaptimmune Therapeutics Plc Product and Services
2.1.5 Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck & Co Inc
2.2.1 Merck & Co Inc Details
2.2.2 Merck & Co Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merck & Co Inc SWOT Analysis
2.2.4 Merck & Co Inc Product and Services
2.2.5 Merck & Co Inc Synovial Sarcoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Immune Design Corp
2.3.1 Immune Design Corp Details
2.3.2 Immune Design Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Immune Design Corp SWOT Analysis
2.3.4 Immune Design Corp Product and Services
2.3.5 Immune Design Corp Synovial Sarcoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Advenchen Laboratories LLC
2.4.1 Advenchen Laboratories LLC Details
2.4.2 Advenchen Laboratories LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Advenchen Laboratories LLC SWOT Analysis
2.4.4 Advenchen Laboratories LLC Product and Services
2.4.5 Advenchen Laboratories LLC Synovial Sarcoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Karyopharm Therapeutics Inc
2.5.1 Karyopharm Therapeutics Inc Details
2.5.2 Karyopharm Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Karyopharm Therapeutics Inc SWOT Analysis
2.5.4 Karyopharm Therapeutics Inc Product and Services
2.5.5 Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 EpiZyme Inc
2.6.1 EpiZyme Inc Details
2.6.2 EpiZyme Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 EpiZyme Inc SWOT Analysis
2.6.4 EpiZyme Inc Product and Services
2.6.5 EpiZyme Inc Synovial Sarcoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Novartis AG
2.7.1 Novartis AG Details
2.7.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Novartis AG SWOT Analysis
2.7.4 Novartis AG Product and Services
2.7.5 Novartis AG Synovial Sarcoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Johnson & Johnson SWOT Analysis
2.8.4 Johnson & Johnson Product and Services
2.8.5 Johnson & Johnson Synovial Sarcoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Immunocore Ltd
2.9.1 Immunocore Ltd Details
2.9.2 Immunocore Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Immunocore Ltd SWOT Analysis
2.9.4 Immunocore Ltd Product and Services
2.9.5 Immunocore Ltd Synovial Sarcoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Millennium Pharmaceuticals Inc
2.10.1 Millennium Pharmaceuticals Inc Details
2.10.2 Millennium Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Millennium Pharmaceuticals Inc SWOT Analysis
2.10.4 Millennium Pharmaceuticals Inc Product and Services
2.10.5 Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Pfizer Inc
2.11.1 Pfizer Inc Details
2.11.2 Pfizer Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Pfizer Inc SWOT Analysis
2.11.4 Pfizer Inc Product and Services
2.11.5 Pfizer Inc Synovial Sarcoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Takara Bio Inc
2.12.1 Takara Bio Inc Details
2.12.2 Takara Bio Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Takara Bio Inc SWOT Analysis
2.12.4 Takara Bio Inc Product and Services
2.12.5 Takara Bio Inc Synovial Sarcoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Synovial Sarcoma Treatment Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Synovial Sarcoma Treatment Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Synovial Sarcoma Treatment Manufacturer Market Share in 2019
3.3.2 Top 6 Synovial Sarcoma Treatment Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Synovial Sarcoma Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Synovial Sarcoma Treatment Sales and Market Share by Regions (2015-2020)
4.1.2 Global Synovial Sarcoma Treatment Revenue and Market Share by Regions (2015-2020)
4.2 North America Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
4.3 Europe Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
4.5 South America Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Synovial Sarcoma Treatment Sales, Revenue and Market Share by Country
5.1.1 North America Synovial Sarcoma Treatment Sales and Market Share by Country (2015-2020)
5.1.2 North America Synovial Sarcoma Treatment Revenue and Market Share by Country (2015-2020)
5.2 United States Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
5.3 Canada Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
5.4 Mexico Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Synovial Sarcoma Treatment Sales, Revenue and Market Share by Country
6.1.1 Europe Synovial Sarcoma Treatment Sales and Market Share by Country (2015-2020)
6.1.2 Europe Synovial Sarcoma Treatment Revenue and Market Share by Country (2015-2020)
6.2 Germany Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
6.3 UK Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
6.4 France Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
6.5 Russia Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
6.6 Italy Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Synovial Sarcoma Treatment Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Synovial Sarcoma Treatment Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Synovial Sarcoma Treatment Revenue and Market Share by Regions (2015-2020)
7.2 China Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
7.3 Japan Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
7.4 Korea Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
7.5 India Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
7.7 Australia Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Synovial Sarcoma Treatment Sales, Revenue and Market Share by Country
8.1.1 South America Synovial Sarcoma Treatment Sales and Market Share by Country (2015-2020)
8.1.2 South America Synovial Sarcoma Treatment Revenue and Market Share by Country (2015-2020)
8.2 Brazil Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
8.3 Argentina Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Synovial Sarcoma Treatment Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Synovial Sarcoma Treatment Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Synovial Sarcoma Treatment Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
9.3 Turkey Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
9.4 Egypt Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
9.5 South Africa Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Synovial Sarcoma Treatment Sales and Market Share by Type (2015-2020)
10.2 Global Synovial Sarcoma Treatment Revenue and Market Share by Type (2015-2020)
10.3 Global Synovial Sarcoma Treatment Price by Type (2015-2020)
11 Global Synovial Sarcoma Treatment Market Segment by Application
11.1 Global Synovial Sarcoma Treatment Sales Market Share by Application (2015-2020)
11.2 Global Synovial Sarcoma Treatment Revenue Market Share by Application (2015-2020)
11.3 Global Synovial Sarcoma Treatment Price by Application (2015-2020)
12 Market Forecast
12.1 Global Synovial Sarcoma Treatment Sales, Revenue and Growth Rate (2021-2025)
12.2 Synovial Sarcoma Treatment Market Forecast by Regions (2021-2025)
12.2.1 North America Synovial Sarcoma Treatment Market Forecast (2021-2025)
12.2.2 Europe Synovial Sarcoma Treatment Market Forecast (2021-2025)
12.2.3 Asia-Pacific Synovial Sarcoma Treatment Market Forecast (2021-2025)
12.2.4 South America Synovial Sarcoma Treatment Market Forecast (2021-2025)
12.2.5 Middle East & Africa Synovial Sarcoma Treatment Market Forecast (2021-2025)
12.3 Synovial Sarcoma Treatment Market Forecast by Type (2021-2025)
12.3.1 Global Synovial Sarcoma Treatment Sales Forecast by Type (2021-2025)
12.3.2 Global Synovial Sarcoma Treatment Market Share Forecast by Type (2021-2025)
12.4 Synovial Sarcoma Treatment Market Forecast by Application (2021-2025)
12.4.1 Global Synovial Sarcoma Treatment Sales Forecast by Application (2021-2025)
12.4.2 Global Synovial Sarcoma Treatment Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Synovial Sarcoma Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Synovial Sarcoma Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Synovial Sarcoma Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Adaptimmune Therapeutics Plc Basic Information, Manufacturing Base and Competitors
Table 8. Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Major Business
Table 9. Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Total Revenue (USD Million) (2018-2019)
Table 10. Adaptimmune Therapeutics Plc SWOT Analysis
Table 11. Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Product and Services
Table 12. Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Merck & Co Inc Basic Information, Manufacturing Base and Competitors
Table 14. Merck & Co Inc Synovial Sarcoma Treatment Major Business
Table 15. Merck & Co Inc Synovial Sarcoma Treatment Total Revenue (USD Million) (2018-2019)
Table 16. Merck & Co Inc SWOT Analysis
Table 17. Merck & Co Inc Synovial Sarcoma Treatment Product and Services
Table 18. Merck & Co Inc Synovial Sarcoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Immune Design Corp Basic Information, Manufacturing Base and Competitors
Table 20. Immune Design Corp Synovial Sarcoma Treatment Major Business
Table 21. Immune Design Corp Synovial Sarcoma Treatment Total Revenue (USD Million) (2018-2019)
Table 22. Immune Design Corp SWOT Analysis
Table 23. Immune Design Corp Synovial Sarcoma Treatment Product and Services
Table 24. Immune Design Corp Synovial Sarcoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Advenchen Laboratories LLC Basic Information, Manufacturing Base and Competitors
Table 26. Advenchen Laboratories LLC Synovial Sarcoma Treatment Major Business
Table 27. Advenchen Laboratories LLC Synovial Sarcoma Treatment Total Revenue (USD Million) (2018-2019)
Table 28. Advenchen Laboratories LLC SWOT Analysis
Table 29. Advenchen Laboratories LLC Synovial Sarcoma Treatment Product and Services
Table 30. Advenchen Laboratories LLC Synovial Sarcoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Karyopharm Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 32. Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Major Business
Table 33. Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Total Revenue (USD Million) (2018-2019)
Table 34. Karyopharm Therapeutics Inc SWOT Analysis
Table 35. Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Product and Services
Table 36. Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. EpiZyme Inc Basic Information, Manufacturing Base and Competitors
Table 38. EpiZyme Inc Synovial Sarcoma Treatment Major Business
Table 39. EpiZyme Inc Synovial Sarcoma Treatment Total Revenue (USD Million) (2018-2019)
Table 40. EpiZyme Inc SWOT Analysis
Table 41. EpiZyme Inc Synovial Sarcoma Treatment Product and Services
Table 42. EpiZyme Inc Synovial Sarcoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 44. Novartis AG Synovial Sarcoma Treatment Major Business
Table 45. Novartis AG Synovial Sarcoma Treatment Total Revenue (USD Million) (2018-2019)
Table 46. Novartis AG SWOT Analysis
Table 47. Novartis AG Synovial Sarcoma Treatment Product and Services
Table 48. Novartis AG Synovial Sarcoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 50. Johnson & Johnson Synovial Sarcoma Treatment Major Business
Table 51. Johnson & Johnson Synovial Sarcoma Treatment Total Revenue (USD Million) (2018-2019)
Table 52. Johnson & Johnson SWOT Analysis
Table 53. Johnson & Johnson Synovial Sarcoma Treatment Product and Services
Table 54. Johnson & Johnson Synovial Sarcoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Immunocore Ltd Basic Information, Manufacturing Base and Competitors
Table 56. Immunocore Ltd Synovial Sarcoma Treatment Major Business
Table 57. Immunocore Ltd Synovial Sarcoma Treatment Total Revenue (USD Million) (2018-2019)
Table 58. Immunocore Ltd SWOT Analysis
Table 59. Immunocore Ltd Synovial Sarcoma Treatment Product and Services
Table 60. Immunocore Ltd Synovial Sarcoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Millennium Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 62. Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Major Business
Table 63. Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Total Revenue (USD Million) (2018-2019)
Table 64. Millennium Pharmaceuticals Inc SWOT Analysis
Table 65. Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Product and Services
Table 66. Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Inc Synovial Sarcoma Treatment Major Business
Table 69. Pfizer Inc Synovial Sarcoma Treatment Total Revenue (USD Million) (2018-2019)
Table 70. Pfizer Inc SWOT Analysis
Table 71. Pfizer Inc Synovial Sarcoma Treatment Product and Services
Table 72. Pfizer Inc Synovial Sarcoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Takara Bio Inc Basic Information, Manufacturing Base and Competitors
Table 74. Takara Bio Inc Synovial Sarcoma Treatment Major Business
Table 75. Takara Bio Inc Synovial Sarcoma Treatment Total Revenue (USD Million) (2018-2019)
Table 76. Takara Bio Inc SWOT Analysis
Table 77. Takara Bio Inc Synovial Sarcoma Treatment Product and Services
Table 78. Takara Bio Inc Synovial Sarcoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Global Synovial Sarcoma Treatment Sales by Manufacturer (2018-2019) (K Pcs)
Table 80. Global Synovial Sarcoma Treatment Revenue by Manufacturer (2018-2019) (USD Million)
Table 81. Global Synovial Sarcoma Treatment Sales by Regions (2015-2020) (K Pcs)
Table 82. Global Synovial Sarcoma Treatment Sales Market Share by Regions (2015-2020)
Table 83. Global Synovial Sarcoma Treatment Revenue by Regions (2015-2020) (USD Million)
Table 84. North America Synovial Sarcoma Treatment Sales by Countries (2015-2020) (K Pcs)
Table 85. North America Synovial Sarcoma Treatment Sales Market Share by Countries (2015-2020)
Table 86. North America Synovial Sarcoma Treatment Revenue by Countries (2015-2020) (USD Million)
Table 87. North America Synovial Sarcoma Treatment Revenue Market Share by Countries (2015-2020)
Table 88. Europe Synovial Sarcoma Treatment Sales by Countries (2015-2020) (K Pcs)
Table 89. Europe Synovial Sarcoma Treatment Sales Market Share by Countries (2015-2020)
Table 90. Europe Synovial Sarcoma Treatment Revenue by Countries (2015-2020) (USD Million)
Table 91. Asia-Pacific Synovial Sarcoma Treatment Sales by Regions (2015-2020) (K Pcs)
Table 92. Asia-Pacific Synovial Sarcoma Treatment Sales Market Share by Regions (2015-2020)
Table 93. Asia-Pacific Synovial Sarcoma Treatment Revenue by Regions (2015-2020) (USD Million)
Table 94. South America Synovial Sarcoma Treatment Sales by Countries (2015-2020) (K Pcs)
Table 95. South America Synovial Sarcoma Treatment Sales Market Share by Countries (2015-2020)
Table 96. South America Synovial Sarcoma Treatment Revenue by Countries (2015-2020) (USD Million)
Table 97. South America Synovial Sarcoma Treatment Revenue Market Share by Countries (2015-2020)
Table 98. Middle East & Africa Synovial Sarcoma Treatment Sales by Countries (2015-2020) (K Pcs)
Table 99. Middle East & Africa Synovial Sarcoma Treatment Sales Market Share by Countries (2015-2020)
Table 100. Middle East & Africa Synovial Sarcoma Treatment Revenue by Countries (2015-2020) (USD Million)
Table 101. Middle East & Africa Synovial Sarcoma Treatment Revenue Market Share by Countries (2015-2020)
Table 102. Global Synovial Sarcoma Treatment Sales by Type (2015-2020) (K Pcs)
Table 103. Global Synovial Sarcoma Treatment Sales Share by Type (2015-2020)
Table 104. Global Synovial Sarcoma Treatment Revenue by Type (2015-2020) (USD Million)
Table 105. Global Synovial Sarcoma Treatment Revenue Share by Type (2015-2020)
Table 106. Global Synovial Sarcoma Treatment Sales by Application (2015-2020) (K Pcs)
Table 107. Global Synovial Sarcoma Treatment Sales Share by Application (2015-2020)
Table 108. Global Synovial Sarcoma Treatment Sales Forecast by Regions (2021-2025) (K Pcs)
Table 109. Global Synovial Sarcoma Treatment Market Share Forecast by Regions (2021-2025)
Table 110. Global Synovial Sarcoma Treatment Sales Forecast by Type (2021-2025) (K Pcs)
Table 111. Global Synovial Sarcoma Treatment Market Share Forecast by Type (2021-2025)
Table 112. Global Synovial Sarcoma Treatment Sales Forecast by Application (2021-2025)
Table 113. Global Synovial Sarcoma Treatment Market Share Forecast by Application (2021-2025)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Synovial Sarcoma Treatment Picture
Figure 2. Global Sales Market Share of Synovial Sarcoma Treatment by Type in 2019
Figure 3. ACXT-3102 Picture
Figure 4. AL-3818 Picture
Figure 5. Axitinib Picture
Figure 6. CMB-305 Picture
Figure 7. CUE-102 Picture
Figure 8. Others Picture
Figure 9. Synovial Sarcoma Treatment Sales Market Share by Application in 2018
Figure 10. Hospital Picture
Figure 11. Clinic Picture
Figure 12. Others Picture
Figure 13. Global Synovial Sarcoma Treatment Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Synovial Sarcoma Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Synovial Sarcoma Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Synovial Sarcoma Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Synovial Sarcoma Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Synovial Sarcoma Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Synovial Sarcoma Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Synovial Sarcoma Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Synovial Sarcoma Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Synovial Sarcoma Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Synovial Sarcoma Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Synovial Sarcoma Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Synovial Sarcoma Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Synovial Sarcoma Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Synovial Sarcoma Treatment Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Synovial Sarcoma Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Synovial Sarcoma Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Synovial Sarcoma Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Synovial Sarcoma Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Synovial Sarcoma Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Synovial Sarcoma Treatment Sales Market Share by Manufacturer in 2019
Figure 34. Global Synovial Sarcoma Treatment Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Synovial Sarcoma Treatment Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Synovial Sarcoma Treatment Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 39. Global Synovial Sarcoma Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Synovial Sarcoma Treatment Revenue Market Share by Regions (2015-2020)
Figure 41. Global Synovial Sarcoma Treatment Revenue Market Share by Regions in 2018
Figure 42. North America Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
Figure 43. Europe Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
Figure 45. South America Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020)
Figure 47. North America Synovial Sarcoma Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Synovial Sarcoma Treatment Sales Market Share by Countries (2015-2020)
Figure 49. North America Synovial Sarcoma Treatment Sales Market Share by Countries in 2018
Figure 50. North America Synovial Sarcoma Treatment Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Synovial Sarcoma Treatment Revenue Market Share by Countries in 2018
Figure 52. United States Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Canada Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Mexico Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Europe Synovial Sarcoma Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Synovial Sarcoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Synovial Sarcoma Treatment Revenue Market Share by Countries in 2019
Figure 58. Germany Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. UK Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. France Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Russia Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Italy Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Asia-Pacific Synovial Sarcoma Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Synovial Sarcoma Treatment Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Synovial Sarcoma Treatment Revenue Market Share by Regions 2019
Figure 66. China Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Korea Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. India Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Southeast Asia Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. South America Synovial Sarcoma Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Synovial Sarcoma Treatment Sales Market Share by Countries in 2019
Figure 73. South America Synovial Sarcoma Treatment Revenue Market Share by Countries in 2019
Figure 74. Brazil Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Argentina Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Middle East and Africa Synovial Sarcoma Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Synovial Sarcoma Treatment Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Synovial Sarcoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Synovial Sarcoma Treatment Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Egypt Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Turkey Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. South Africa Synovial Sarcoma Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Global Synovial Sarcoma Treatment Sales and Growth Rate (2021-2025) (K Pcs)
Figure 85. Global Synovial Sarcoma Treatment Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Synovial Sarcoma Treatment Market Forecast (2021-2025) (K Pcs)
Figure 87. Europe Sales Synovial Sarcoma Treatment Market Forecast (2021-2025) (K Pcs)
Figure 88. Asia-Pacific Sales Synovial Sarcoma Treatment Market Forecast (2021-2025) (K Pcs)
Figure 89. South America Sales Synovial Sarcoma Treatment Market Forecast (2021-2025) (K Pcs)
Figure 90. Middle East & Africa Sales Synovial Sarcoma Treatment Market Forecast (2021-2025) (K Pcs)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
軟骨無形成症治療の世界市場 2020年 Market Overview The global Achondroplasia Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Achondroplasia Treat…- 酒さ治療の世界市場 2020年 Market Overview The global Rosacea Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.1% in the forecast period of 2020 to 2025 and will expected to reach USD 1721.7 million by 2025, from USD 1526 million in 2019. The Rosacea Treatment ma…
- グロボイド細胞白質ジストロフィー治療の世界市場 2020年 Market Overview The global Globoid Cell Leukodystrophy Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Globoid…
- 水腎症治療の世界市場 2020年 Market Overview The global Hydronephrosis Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hydronephrosis Treat…
- 多発性内分泌腫瘍治療の世界市場 2020年 Market Overview The global Multiple Endocrine Neoplasia Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Multip…